Certification and role of local pathologists for diffuse large B-cell lymphoma (DLBCL) subtyping and eligibility determination in the phase II PYRAMID study.
Jonathan W. Said
Other Remuneration - Millennium
James Andrew Reeves
No relevant relationships to disclose
Ian Flinn
Research Funding - Millennium
Anil Tulpule
No relevant relationships to disclose
Robert Leon Robles
No relevant relationships to disclose
Christopher Flowers
Consultant or Advisory Role - Allos Therapeutics; Celgene; Genentech (U); Millennium (U); Roche (U); Seattle Genetics; Spectrum Pharmaceuticals
Research Funding - Millennium; Novartis; Spectrum Pharmaceuticals
Nicholas J. DiBella
No relevant relationships to disclose
Kathryn S. Kolibaba
Research Funding - Pharmacyclics
Parameswaran Venugopal
No relevant relationships to disclose
Tatjana Kolevska
No relevant relationships to disclose
Sven De Vos
Honoraria - Millennium
Research Funding - Millennium
David L. Jaye
Honoraria - Millennium
Dixie Esseltine
Employment or Leadership Position - Millennium
Stock Ownership - Takeda
George Mulligan
Employment or Leadership Position - Millennium
Stock Ownership - Millennium
Maria Margarita Corvez
Employment or Leadership Position - Millennium
Stock Ownership - Millennium
John R. Eckardt
Consultant or Advisory Role - DAVAOncology
Bryan Brockman
Consultant or Advisory Role - DAVAOncology
Isagani M. Chico
No relevant relationships to disclose
John Leonard
Consultant or Advisory Role - Millennium
Honoraria - Millennium
Steven Kussick
Employment or Leadership Position - PhenoPath Laboratories
Stock Ownership - PhenoPath Laboratories